2024. Pathological complete response after neoadjuvant cyclin-dependent kinase 4/6 inhibitor and neoadjuvant endocrine therapy in locally advanced hormone receptor-positive breast cancer. Indian Journal of Case Reports. 10, 10 (Sep. 2024), 322–324. DOI:https://doi.org/10.32677/ijcr.v10i10.4727.